Screener
Haemonetics HAE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's enterprise value?
- Haemonetics (HAE) reported enterprise value of $4.36B in Q2 2026.
- How has Haemonetics's enterprise value changed year-over-year?
- Haemonetics's enterprise value decreased by 1.9% year-over-year, from $4.44B to $4.36B.
- What is the long-term trend for Haemonetics's enterprise value?
- Over 5 years (2021 to 2026), Haemonetics's enterprise value has grown at a -10.2% compound annual growth rate (CAGR), from $6.26B to $3.65B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Haemonetics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude